NBIX vs SAZ
Neurocrine Biosciences Inc (NBIX) versus Saratoga Investment Corp 8.50% (SAZ) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Saratoga Investment Corp 8.50% (SAZ) common stock listed on NYSE.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
SAZ does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SAZ currently screens at market cap $0.
Not investment advice. Open the NBIX and SAZ stock pages for the full models.
Not investment advice.